Why Enphase Is Wednesday’s Big Earnings Winner
Enphase Energy soared after it released its second-quarter financial results before the markets opened on Wednesday.
All Work
Chris Lange
Why FireEye Fell Short in Q2
FireEye shares plunged Wednesday after the cybersecurity firm reported its most recent quarterly results late on Tuesday.
Why Amgen Is Up Despite Falling Product Sales
Amgen shares rose early Wednesday after it released better than expected second-quarter financial results late on Tuesday.
How Apple Won Out in Q3
Apple released its most recent quarterly results after the markets closed on Tuesday. The iPhone giant said that it had $2.18 in earnings per share (EPS) and $53.8 billion in revenue, compared with consensus…
Why AMD Is Stumbling After Earnings
AMD reported its second quarter financial results after the markets closed on Tuesday. The firm posted $0.08 in earnings per share (EPS) and $1.53 billion in revenue, compared with consensus estimates that called for…
What to Look For in GE’s Report Wednesday Morning
General Electric is set to report its most recent quarterly results before the markets open on Wednesday and analyst sentiment is muted.
Are Grubhub Earnings Really That Unappetizing?
Grubhub shares retreated after it released mixed second-quarter financial results before the markets opened on Tuesday.
What to Expect When Apple Reports After the Close
Apple is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday, and at least one analyst has a cautious view.
How Procter & Gamble Is Pulling Ahead With Q4 Earnings
Procter & Gamble reported better than expected fiscal fourth-quarter financial results before the markets opened on Tuesday.
Why Keytruda Made All the Difference in Merck’s Q2
Merck released better than expected second-quarter financial results before the markets opened on Tuesday.
What to Expect When Apple Reports Late on Tuesday
Apple is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday.
What to Look For in Procter & Gamble’s Report on Tuesday
Procter &Gamble is set to report its most recent quarterly results before the markets open on Tuesday, and modest year-over-year growth on the top and bottom lines is expected.
What to Watch When Merck and Pfizer Report Early on Tuesday
Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of the Dow Jones industrials that are reporting this week, but they make up half…
Is This Lexicon Pharmaceuticals Panic Overblown?
Lexicon Pharma shares were absolutely crushed on Monday after it was announced that Sanofi would be ending its partnership with the firm.
What to Expect When Beyond Meat Reports After the Close
Beyond Meat is scheduled to release its most recent quarterly results after the markets close on Monday, and Wall Stree sentiment is somewhat muted.
What This Mylan-Pfizer Pharma Juggernaut Will Look Like
Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update to its business involving Pfizer and that CEO Heather Bresch is resigning.
AMD, GE, GM, Qualcomm, Square and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of General Electric, General Motors and the other most prominent earnings reports expected this week.
Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including Apple, Exxon and Pfizer.
Major Biotechs See Rising Tide in Short Interest
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Should Amazon Get More Credit For Q2 Results?
Amazon released its second quarter financial results after the markets closed on Thursday. The e-commerce empire said that it had $5.22 in earnings per share (EPS) and $63.4 billion in revenue, compared with consensus…